Analgesic and antiinflammatory effects of cannabinoid receptor agonists in a rat model of neuropathic pain

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 379, Issue 6, 2009, Pages 627-636

  Leichsenring, Anna ^a   Andriske, Michael ^a   Bäcker, Ingo ^a   Stichel, Christine C ^a,b   Lübbert, Hermann ^a,b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b Biofrontera Pharmaceuticals GmbH   (Germany)

Author keywords

Allodynia; Chronic treatment; Gliosis; GW405833; Spinal cord; WIN55,212 2

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID RECEPTOR AGONIST; CATHEPSIN S; CATHEPSIN X; GW 405833; UNCLASSIFIED DRUG; 1-(2,3-DICHLOROBENZOYL)-5-METHOXY-2-METHYL-(2-(MOPHOLIN-4-YL)ETHYL)-1H-INDOLE; ANALGESIC AGENT; BENZOXAZINE DERIVATIVE; CANNABINOID; CANNABINOID RECEPTOR; INDOLE DERIVATIVE; MORPHOLINE DERIVATIVE; NAPHTHALENE DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT;

ALLODYNIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; GLIA; GLIOSIS; IMMUNOHISTOCHEMISTRY; MALE; NEUROPATHIC PAIN; NONHUMAN; PROTEIN EXPRESSION; RAT; SPINAL CORD; ANIMAL; COMPARATIVE STUDY; DISEASE MODEL; NEURALGIA; PAIN; PATHOLOGY; PHYSIOLOGY; WISTAR RAT;

ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BENZOXAZINES; CANNABINOIDS; DISEASE MODELS, ANIMAL; INDOLES; MALE; MORPHOLINES; NAPHTHALENES; NEURALGIA; PAIN; RATS; RATS, WISTAR; RECEPTORS, CANNABINOID; CANNABINOID RECEPTOR AGONISTS;

EID: 64749087048     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-008-0386-4     Document Type: Article

References (57)

1. A Ameri 1999 The effects of cannabinoids on the brain Prog Neurobiol 58 315 348
2. A Arevalo-Martin JM Vela E Molina-Holgado J Borrell C Guaza 2003 Therapeutic action of cannabinoids in a murine model of multiple sclerosis J Neurosci 23 2511 2516
3. CH Ashton 1999 Adverse effects of cannabis and cannabinoids Br J Anaesth 83 637 649
4. J Barclay AK Clark P Ganju C Gentry S Patel G Wotherspoon F Buxton C Song J Ullah J Winter A Fox S Bevan M Malcangio 2007 Role of the cysteine protease cathepsin S in neuropathic hyperalgesia Pain 130 225 234
5. P Beaulieu M Ware 2007 Reassessment of the role of cannabinoids in the management of pain Curr Opin Anaesthesiol 20 473 477
6. M Beltramo N Bernardini R Bertorelli M Campanella E Nicolussi S Fredduzzi A Reggiani 2006 CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms Eur J Neurosci 23 1530 1538
7. J Blackbeard KP O'Dea VC Wallace A Segerdahl T Pheby M Takata MJ Field AS Rice 2007 Quantification of the rat spinal microglial response to peripheral nerve injury as revealed by immunohistochemical image analysis and flow cytometry J Neurosci Methods 164 207 217
8. AS Bloom WL Dewey 1978 A comparison of some pharmacological actions of morphine and delta9-tetrahydrocannabinol in the mouse Psychopharmacology (Berl) 57 243 248
9. D Bridges K Ahmad AS Rice 2001 The synthetic cannabinoid WIN55,212-2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain Br J Pharmacol 133 586 594
10. FA Campbell MR Tramer D Carroll DJ Reynolds RA Moore HJ McQuay 2001 Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review BMJ 323 13 16
11. Y Cheng SA Hitchcock 2007 Targeting cannabinoid agonists for inflammatory and neuropathic pain Expert Opin Investig Drugs 16 951 965
12. AK Clark PK Yip J Grist C Gentry AA Staniland F Marchand M Dehvari G Wotherspoon J Winter J Ullah S Bevan M Malcangio 2007 Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain Proc Natl Acad Sci U S A 104 10655 10660
13. B Costa M Colleoni S Conti AE Trovato M Bianchi ML Sotgiu G Giagnoni 2004 Repeated treatment with the synthetic cannabinoid WIN 55,212-2 reduces both hyperalgesia and production of pronociceptive mediators in a rat model of neuropathic pain Br J Pharmacol 141 4 8
14. JL Croxford SD Miller 2003 Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R + WIN55,212 J Clin Invest 111 1231 1240
15. J De Vry E Kuhl P Franken-Kunkel G Eckel 2004 Pharmacological characterization of the chronic constriction injury model of neuropathic pain Eur J Pharmacol 491 137 148
16. J Ehrhart D Obregon T Mori H Hou N Sun Y Bai T Klein F Fernandez J Tan RD Shytle 2005 Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation J Neuroinflammation 2 29
17. SJ Elmes MD Jhaveri D Smart DA Kendall V Chapman 2004 Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naive rats and in rat models of inflammatory and neuropathic pain Eur J Neurosci 20 2311 2320
18. A Fox A Kesingland C Gentry K McNair S Patel L Urban I James 2001 The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain Pain 92 91 100
19. B Frank MG Serpell J Hughes JN Matthews D Kapur 2008 Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study BMJ 336 199 201
20. F Grotenhermen 2004 Pharmacology of cannabinoids Neuro Endocrinol Lett 25 14 23
21. J Guindon AG Hohmann 2008 Cannabinoid CB(2) receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain Br J Pharmacol 153 319 334
22. T Harkany M Guzman I Galve-Roperh P Berghuis LA Devi K Mackie 2007 The emerging functions of endocannabinoid signaling during CNS development Trends Pharmacol Sci 28 83 92
23. M Herkenham AB Lynn MD Little MR Johnson LS Melvin BR De Costa KC Rice 1990 Cannabinoid receptor localization in brain Proc Natl Acad Sci U S A 87 1932 1936
24. U Herzberg E Eliav GJ Bennett IJ Kopin 1997 The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain Neurosci Lett 221 157 160
25. P Honore SD Rogers MJ Schwei JL Salak-Johnson NM Luger MC Sabino DR Clohisy PW Mantyh 2000 Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons Neuroscience 98 585 598
26. MM Ibrahim H Deng A Zvonok DA Cockayne J Kwan HP Mata TW Vanderah J Lai F Porreca A Makriyannis TP Malan Jr 2003 Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS Proc Natl Acad Sci U S A 100 10529 10533
27. SH Kim JJ Chung 1992 An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat Pain 50 355 363
28. CJ LaBuda PJ Little 2005 Pharmacological evaluation of the selective spinal nerve ligation model of neuropathic pain in the rat J Neurosci Methods 144 175 181
29. A Leichsenring I Bäcker W Wendt M Andriske B Schmitz M Foguet A Mix S McMahon CC Stichel H Lübbert 2008 Differential expression of cathepsin S and X in the spinal cord of a rat neuropathic pain model BMC Neurosci 12 80
30. IJ Lever AS Rice 2007 Cannabinoids and pain Handb Exp Pharmacol 177 265 306
31. C Liu JM Walker 2006 Effects of a cannabinoid agonist on spinal nociceptive neurons in a rodent model of neuropathic pain J Neurophysiol 96 2984 2994
32. J Mao DD Price J Lu L Keniston DJ Mayer 2000 Two distinctive antinociceptive systems in rats with pathological pain Neurosci Lett 280 13 16
33. Y Marchalant S Rosi GL Wenk 2007 Anti-inflammatory property of the cannabinoid agonist WIN-55212-2 in a rodent model of chronic brain inflammation Neuroscience 144 1516 1522
34. LA Matsuda TI Bonner SJ Lolait 1993 Localization of cannabinoid receptor mRNA in rat brain J Comp Neurol 327 535 550
35. SB McMahon WB Cafferty F Marchand 2005 Immune and glial cell factors as pain mediators and modulators Exp Neurol 192 444 462
36. JM McPartland M Glass RG Pertwee 2007 Meta-analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences Br J Pharmacol 152 583 593
37. G Moalem DJ Tracey 2006 Immune and inflammatory mechanisms in neuropathic pain Brain Res Rev 51 240 264
38. S Omoigui 2007 The biochemical origin of pain-proposing a new law of pain: the origin of all pain is inflammation and the inflammatory response. Part 1 of 3-a unifying law of pain Med Hypotheses 69 70 82
39. ES Onaivi H Ishiguro JP Gong S Patel A Perchuk PA Meozzi L Myers Z Mora P Tagliaferro E Gardner A Brusco BE Akinshola QR Liu B Hope S Iwasaki T Arinami L Teasenfitz GR Uhl 2006 Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain Ann N Y Acad Sci 1074 514 536
40. S Ortega-Gutierrez E Molina-Holgado C Guaza 2005 Effect of anandamide uptake inhibition in the production of nitric oxide and in the release of cytokines in astrocyte cultures Glia 52 163 168
41. S Ortega-Gutierrez E Molina-Holgado A revalo-Martin F Correa A Viso ML Lopez-Rodriguez MV Di C Guaza 2005 Activation of the endocannabinoid system as therapeutic approach in a murine model of multiple sclerosis FASEB J 19 1338 1340
42. P Pacher S Batkai G Kunos 2006 The endocannabinoid system as an emerging target of pharmacotherapy Pharmacol Rev 58 389 462
43. D Parolaro 1999 Presence and functional regulation of cannabinoid receptors in immune cells Life Sci 65 637 644
44. M Ringkamp S Eschenfelder EJ Grethel HJ Habler RA Meyer W Janig SN Raja 1999 Lumbar sympathectomy failed to reverse mechanical allodynia- and hyperalgesia-like behavior in rats with L5 spinal nerve injury Pain 79 143 153
45. A Romero-Sandoval JC Eisenach 2007 Spinal cannabinoid receptor type 2 activation reduces hypersensitivity and spinal cord glial activation after paw incision Anesthesiology 106 787 794
46. DR Sagar S Kelly PJ Millns CT O'Shaughnessey DA Kendall V Chapman 2005 Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats Eur J Neurosci 22 371 379
47. WS Sheng S Hu X Min GA Cabral JR Lokensgard PK Peterson 2005 Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes Glia 49 211 219
48. N Stella 2004 Cannabinoid signaling in glial cells Glia 48 267 277
49. KJ Valenzano L Tafesse G Lee JE Harrison JM Boulet SL Gottshall L Mark MS Pearson W Miller S Shan L Rabadi Y Rotshteyn SM Chaffer PI Turchin DA Elsemore M Toth L Koetzner GT Whiteside 2005 Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy Neuropharmacology 48 658 672
50. S Van M Duncan PJ Kingsley A Mouihate P Urbani K Mackie N Stella A Makriyannis D Piomelli JS Davison LJ Marnett M Di V QJ Pittman KD Patel KA Sharkey 2005 Identification and functional characterization of brainstem cannabinoid CB2 receptors Science 310 329 332
51. L Walter A Franklin A Witting C Wade Y Xie G Kunos K Mackie N Stella 2003 Nonpsychotropic cannabinoid receptors regulate microglial cell migration J Neurosci 23 1398 1405
52. T Wang JP Collet S Shapiro MA Ware 2008 Adverse effects of medical cannabinoids: a systematic review CMAJ 178 1669 1678
53. LR Watkins MR Hutchinson A Ledeboer J Wieseler-Frank ED Milligan SF Maier 2007 Norman Cousins Lecture. Glia as the "bad guys": implications for improving clinical pain control and the clinical utility of opioids Brain Behav Immun 21 131 146
54. LR Watkins SF Maier 2003 Glia: a novel drug discovery target for clinical pain Nat Rev Drug Discov 2 973 985
55. GT Whiteside SL Gottshall JM Boulet SM Chaffer JE Harrison MS Pearson PI Turchin L Mark AE Garrison KJ Valenzano 2005 A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833 Eur J Pharmacol 528 65 72
56. BB Yao GC Hsieh JM Frost Y Fan TR Garrison AV Daza GK Grayson CZ Zhu M Pai P Chandran AK Salyers EJ Wensink P Honore JP Sullivan MJ Dart MD Meyer 2007 In vitro and in vivo characterization of A-796260: a selective cannabinoid CB(2) receptor agonist exhibiting analgesic activity in rodent pain models Br J Pharmacol 153 390 401
57. L Znaor S Lovric Q Hogan D Sapunar 2007 Association of neural inflammation with hyperalgesia following spinal nerve ligation Croat Med J 48 35 42